These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 68699)

  • 1. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumors.
    Sedlacek HH; Bengelsdorff KH; Hagmayer G; Seiler FR
    Int J Immunopharmacol; 1987; 9(7):841-50. PubMed ID: 3429076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ; Simon RM; Baker AR
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG.
    Simmons RL; Rios A; Kersey JH
    J Surg Res; 1972 Feb; 12(2):57-61. PubMed ID: 4111004
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 6. Modified tumor cells in the immunotherapy of solid mammary tumors.
    Simmons RL; Rios A; Trites P
    Med Clin North Am; 1976 May; 60(3):551-65. PubMed ID: 1271892
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 8. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
    So SK; Song CW; Rios A; Simmons RL
    J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoimmunotherapy of syngeneic mouse mammary carcinomas employing methanol extraction residue.
    Cohen D; Yron I; Grover NB; Weiss DW
    Ann N Y Acad Sci; 1976; 277(00):195-208. PubMed ID: 793479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isonicotinic acid hydrazide on the intratumor injection of BCG.
    Sparks FC; Albert NE; Breeding JH
    J Natl Cancer Inst; 1977 Feb; 58(2):367-8. PubMed ID: 319244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmented uptake of neuraminidase-treated sheep red blood cells: participation of opsonic factors.
    Schmidtke JR; Simmons RL
    J Natl Cancer Inst; 1975 Jun; 54(6):1379-84. PubMed ID: 48553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.
    Sedlacek HH; Hagmayer G; Seiler FR
    Cancer Immunol Immunother; 1986; 23(3):192-9. PubMed ID: 3791304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of a coupled tumor antigen with specificity against transplanted tumors in C3H/HeJ mice.
    Phillip MJ; Maximuke PP
    Oncology; 1980; 37(1):1-5. PubMed ID: 6153125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.